Saying a lot in very few words…
Monday, July 7th, 2008Earlier today, Fresenius SE (FRE3:GY) announced that it was buying APP Pharmaceuticals (APPX) for $4.6 billion, or around $23 a share. The deal represented a substantial premium — just shy of 30% — over where APP’s shares closed on Thursday, before the markets closed for the July 4 holiday.
But what’s really interesting is this 8K [...]



RSS